Therefore, co-immunostaining of SRPX2 and p-SMAD2/3, key factors in TGF-β signaling pathway, was next conducted in TGF-β1 treated HPFs, BLM induced mice's lung sections and IPF patients' lung sections, respectively. The gene discussed is SMAD2; the disease is idiopathic pulmonary fibrosis.